PDI - Resultado de Búsqueda

Carlos Miguel Perez Cortes

decano

Universidad San Sebastián

santiago, Chile

Médico-Cirujano, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 1984

Decano Full Time

UNIVERSIDAD SAN SEBASTIAN

Medicina y Ciencia

Santiago, Chile

2019 - A la fecha


Chilean Health Care Providers’ Perceived Comfort in Performing Oral Rapid Testing for HIV: A Cross-Sectional Study Article SCOPUS Hispanic Health Care International (2020)
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial Squires, Kathleen; Sax, Paul E.; Cahn, Pedro; Lombaard, Johan; Lai, Ming-Tain; Rodgers, Anthony; Lupinacci, Lisa; Kumar, Sushma; Hanna, George J.; Hwang, Carey; et al. Article ISI LANCET HIV (2020)
Claves prácticas para un trasplante de microbiota fecal por colonoscopía en infección por Clostridium difficile recurrente. Experiencia en un centro universitario Ricardo Cruz; Hugo, Monrroy; Jorge Flandez; Carlos M. Pérez Article SCIELO SCOPUS Revista chilena de infectología : órgano oficial de la Sociedad Chilena de Infectología (2018)
Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial Ratanasuwan, Winai; Rassool, Mohammed; Bloch, Mark; Xu, Xia; Homony, Brenda; Hepler, Deborah; Greaves, Wayne; ONCEMRK Study Grp Article ISI JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2018)
Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis Wolff, Marcelo; SECOND-LINE Study Grp Article ISI LANCET HIV (2015)
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study Becker, Stephen; Belloso, Waldo; To, Marta Boffi; Cooper, David; Crabtree-Ramirez, Brenda; Duncombe, Chris; Foulkes, Sharne; Jessen, Heiko; Kumar, Suresh; Lee, Man-Po; et al. Article ISI LANCET INFECTIOUS DISEASES (2015)
Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naive HIV-Infected Patients: Results of the ENCORE1 Study Dickinson, L.; Amin, J.; Else, L.; Boffito, M.; Egan, D.; Khoo, S.; Back, D.; Orrell, C.; Clarke, A.; Phanuphak P.; et al. Article ISI CLINICAL PHARMACOLOGY THERAPEUTICS (2015)
Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial Puls, Rebekah L.; Phanuphak, Praphan; Nwizu, Chidi; Young, Barnaby; Shahar, Eduardo; Wolff, Marcelo; Gazzard, Brian; Read, Tim; Hill, Andrew; ENCORE1 Study Grp Article ISI LANCET (2014)
Outcomes of Influenza A(H1N1)pdm09 Virus Infection: Results from Two International Cohort Studies Lynfield, Ruth; Davey, Richard; Dwyer, Dominic E.; Losso, Marcelo H.; Wentworth, Deborah; Cozzi-Lepri, Alessandro; Herman-Lamin, Kathy; Cholewinska, Grazyna; David, Daniel; Kuetter, Stefan; et al. Article ISI PloS one (2014)
Prevalence of R5 and X4 HIV variants in antiretroviral treatment experienced patients with virologic failure Ferrer P, Tello M, Montecinos L, Tordecilla R, Rodríguez C, Beltrán C, Guzmán MA, Ferrés M, Pérez CM, Afani A. Article ISI SCOPUS JOURNAL OF CLINICAL VIROLOGY (2014)
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study Pozniak, Anton L.; Mingrone, Horacio; Shuldyakov, Andrey; Brites, Carlos; Andrade-Villanueva, Jaime F.; Richmond, Gary; Beltran Buendia, Carlos; Fourie, Jan; Ramgopal, Moti; Hagins, Debbie; et al. Article ISI LANCET (2013)
HIV-1 tropism: a comparison between RNA and proviral DNA in routine clinical samples from Chilean patients Ferrer, P; Montecinos L.; Tello, M.; Tordecilla, R; RODRIGUEZ, C; Ferres M; Perez, CM; Beltran, C; Afani, A Article ISI SCOPUS Virology Journal (2013)
HIV-related symptoms and patient clusters among Chileans living with HIV Araya, AX; Norr, KF; Perez, CM; Levy, JA; Park, CG; Kim, MJ Article ISI SCOPUS AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV (2013)
Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study Boyd, M. A.; Moore, C. L.; Nwizu, C.; Losso, M. H.; Mohapi, L.; Sohn, A. H.; Teppler, H.; Van de Steen, O.; Emery S.; Cooper, D. A.; et al. Article ISI LANCET (2013)
Pandemic influenza A (H1N1) in HIV-1-infected patients Perez, CM; Dominguez, MI; Ceballos ME; Moreno C.; Rabagliati, R; Vasquez, P; Lasso M.; Serri M. Article ISI SCOPUS AIDS (2010)


Historia Natural de la infección por VIH en SIDA Cuarta Edición Carlos Pérez BookSection (2009)
Infección por VIH en el embarazo y recién nacido. En Neonatología Carlos Pérez BookSection (2008)
Consideraciones sobre antibioticoterapia empírica en la sepsis severa en Sepsis y falla multiorgánica Castro, Jose; Carlos Romero BookSection


Teniosis: Serie clínica en 35 pacientes Marisa Torres; Carlos Pérez; ERCIRA GALDAMEZ; MELVIN GABOR; Claudio Miranda; XIMENA COFRE; PAULA TELLEZ CaseReport SCIELO PARASITOLOGIA AL DIA (2001)


Virological and immunological outcomes to antiretroviral therapy in HIV-infected patients of an academic medical center in Chile Álvaro Rojas; Paulina Donato; Marcos Huilcamán; Gonzalo Rivera; Tania López; Catalina Gutiérrez; Jaime Labarca Comentario ISI SCIELO SCOPUS Revista chilena de infectología : órgano oficial de la Sociedad Chilena de Infectología (2016)


Rock grindability estimation based on the quaternion color extraction model Schulz, D. ConferencePaper SCOPUS 26th International Mineral Processing Congress, IMPC 2012: Innovative Processing for Sustainable Growth - Conference Proceedings (2012)


H1N1 pandemic influenza impact on hand hygiene and specific precautions compliance among healthcare workers Labarca, J; Zambrano, A; Niklitschek, S; Ferres M; Pérez, C.; Rabagliati, R; Ajenjo, MC Letter ISI SCOPUS Journal of Hospital Infection (2011)
Rates of Hospital-Acquired Influenza Due to the Pandemic H1N1 Virus in 2009, Compared with Seasonal Influenza Rabagliati, R; Labarca, J; Siri L.; Ferres M Letter ISI SCOPUS Infection Control and Hospital Epidemiology (2011)

4

Marcela Ferres

Head of Department

Pediatric Infectious Diseases and Immunology

Pontificia Universidad Católica de Chile

Santiago, Chile

1

Marisa Torres

Profesor Adjunto

Public Health

Pontificia Universidad Católica de Chile

Santiago, Chile

2

Alejandra Araya

Profesor Investigador

Enfermeria

Universidad Andrés Bello

Santiago, Chile

1

Lisette Irarrazabal

Profesor Asistente

Salud del Adulto y Senescente

Pontificia Universidad Católica de Chile

Santiago, Chile

1

Patricia Vasquez

2

Mario Tello

Académico

Biología

Universidad de Santiago de Chile

Santiago, Chile

2

Alejandro Afani

Director

Medicina

Hospital Clinico Universidad de Chile

Santiago, Chile

1

Cristian Hernández

Assistant Professor

Gastroenterology

Pontificia Universidad Católica de Chile

Santiago, Chile

1

Hugo Monrroy

Instructor Adjunto

Gastroenterología

Pontificia Universidad Católica de Chile

Santiago, Chile

2

Pablo Ferrer

Jefe Laboratorio

Medicina Interna

Hospital Clínico Universidad de Chile

Santiago, Chile

1

Gonzalo Rivera

JEFE UNIDAD PACIENTE CRITICO ADULTOS

HOSPITAL HERNAN HENRIQUEZ ARAVENA

TEMUCO, Chile

2

María Elena Ceballos

Profesor Asistente

Enfermedades Infecciosas del Adulto

Pontificia Universidad Católica de Chile

Santiago, Chile

23

Carlos Perez

decano

Universidad San Sebastián

santiago, Chile